RECRUITING

Building Research for Intervention Development in Gliosis and Eating Habits

Talk to us

Conditions

GliosisChild ObesityEating

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this study is to 1) use magnetic resonance imaging (MRI) to evaluate the effect of nutritious foods on inflammation in the human hypothalamus of children and 2) assess the feasibility and acceptability of nutritious food feeding intervention strategies in children with overweight or obesity.

Official Title

Fostering Patient-oriented Research in Cardiometabolic Disease Pathogenesis and Prevention

Quick Facts

Study Start:2025-04-03
Study Completion:2029-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06870578

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:9 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Study1: Adult caregiver and Child age 9-11y. Willing to come to in-person focus group
  2. * Study 2: Age 9-11y, BMI ≥85th and ≤95th percentile for age and sex
  3. * Study 3:Adult caregiver with child who qualify for free or reduced-cost lunch in WA State. Child age 9-11y and with overweight.
  4. * Significant health conditions including type 2 diabetes
  5. * History of major weight loss or eating disorder
  6. * Current use of medications known to alter appetite or body weight (e.g., stimulants for ADHD)
  7. * Documented cognitive disorder
  8. * Severe food allergies, vegetarian, or vegan (Study 1 only)
  9. * Unable to make the session date
  10. * Significant health conditions including type 2 diabetes
  11. * History of major weight loss or eating disorder
  12. * Current use of medications known to alter appetite or body weight (e.g., stimulants for ADHD)
  13. * Documented cognitive disorder
  14. * MRI contraindication (e.g., braces, claustrophobia)
  15. * Weight \>330 pounds (MRI limit)
  16. * Severe food allergies, vegetarian, or vegan
  17. * Currently in formal weight loss program
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

BRIDGE Study
CONTACT
206 616-6360
bridge-study@uw.edu

Principal Investigator

Ellen Schur, MD
PRINCIPAL_INVESTIGATOR
University of Washington

Study Locations (Sites)

University of Washington
Seattle, Washington, 98109
United States

Collaborators and Investigators

Sponsor: University of Washington

  • Ellen Schur, MD, PRINCIPAL_INVESTIGATOR, University of Washington

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-03
Study Completion Date2029-06

Study Record Updates

Study Start Date2025-04-03
Study Completion Date2029-06

Terms related to this study

Additional Relevant MeSH Terms

  • Gliosis
  • Child Obesity
  • Eating